Skip to main content
. 2021 Feb 2;14(2):302–313. doi: 10.14202/vetworld.2021.302-313

Figure-2.

Figure-2

The percentage of eggs that hatched at a discriminating dose (DD) of 0.1 µg/mL thiabendazole and eggs that developed to third stage (infective) larvae in the DD of thiabendezole (0.02 μg/mL) in the macro-agar larval development test.